Home › Gallbladder Cancer › Texas › Houston
Gallbladder Cancer clinical trials in Houston, TX
4 studies for Gallbladder Cancer are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
RecruitingPhase 3
- Research Site, Houston
About Gallbladder Cancer
Gallbladder cancer is difficult to diagnose because there are no symptoms in its early stages. Read about tests, treatment options and prognosis.
More about Gallbladder Cancer on MedlinePlus
Gallbladder Cancer trials in other cities
- Nashville, TN5 studies
- Baldwin Park, CA4 studies
- Boston, MA4 studies
- Dallas, TX3 studies
- Oklahoma City, OK3 studies
- New York City, NY3 studies
- Seattle, WA3 studies
- Cleveland, OH3 studies
- Louisville, KY3 studies
- Los Angeles, CA3 studies
- Pittsburgh, PA3 studies
- Birmingham, AL3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.